Royal Bank of Canada
ACUR

Royal Bank of Canada’s Acura Pharmaceuticals ACUR Stock Holding History

Royal Bank of Canada’s Portfolio ACUR Stock Details ACUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-40
Closed – – 6941
2016
Q3 		$0 Buy
+40
New +$71 ﹤0.01% 6751
2015
Q2 		– Sell
-7
Closed – – 6853
2015
Q1 		$0 Buy
+7
New +$22 ﹤0.01% 6607
2013
Q3 		– Sell
-1,251
Closed -$11K – 6395
2013
Q2 		$11K Buy
+1,251
New +$14.1K ﹤0.01% 5259

Other funds holding ACUR

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 19.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
FWP
FAS Wealth Partners Leawood, Kansas $1.92B AUM 26.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Royal Bank of Canada's ACUR Position: Q4 2016 in Review

Royal Bank of Canada sold out of Acura Pharmaceuticals (ACUR) in Q4 2016, closing a stake of 40 shares.

Royal Bank of Canada first reported a position in ACUR in Q2 2013 and held it in 3 quarters. The position peaked at $11K in Q2 2013. 22 funds tracked by Wall St. Rank hold ACUR as of Q4 2016.

  • Royal Bank of Canada reported no remaining Acura Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Royal Bank of Canada sold 40 Acura Pharmaceuticals shares in Q4 2016.
  • Royal Bank of Canada first reported a position in Acura Pharmaceuticals in Q2 2013 and held it in 3 quarters.
  • Royal Bank of Canada's Acura Pharmaceuticals position peaked at $11K in Q2 2013.
  • 22 funds tracked by Wall St. Rank held Acura Pharmaceuticals as of Q4 2016.

Based on Royal Bank of Canada's 13F filing for Q4 2016, filed 14 Feb 2017.